Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Executive Summary Written by Jonathan Wright, British Clinical Pharmacist Last reviewed: February 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have transformed the treatment of obesity and type 2 diabetes
Several factors, including genetics, sun exposure, and certain medical conditions can influence melanin production
Effects of lavender aroma on sleep quality in healthy Japanese students
Participants were organised into four groups based on their confirmed serum HIV and TB statusHIV-only ( n = 7), TB-only ( n = 41), HIV/TB co-infected ( n = 9), and healthy controls ( n = 32)
Weight gain after GLP-1 RAs The high and increasing prevalence of women with obesity in the United States who become pregnant is accompanied by a greater risk of developing type 2 diabetes during pregnancy
doi:10.3390/ijms23052717 Bloomer RJ, Tschume LC, Smith WA
US$ 28.94
US$ 20.03
US$ 27.04
US$ 23.01
US$ 28.62
